Delivery Order SPE2DB20D3101-SPE2DB23FRFN8
- Not listed
- This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL syringes to the Defense Logistics Agency (DLA). The $1,465.38 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of August 4, 2021 and was awarded on August 3, 2021. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,022.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 12, 2025, with a completion date of February 13, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml to the Defense Logistics Agency (DLA). The $2,440.77 firm fixed-price delivery order was issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc., doing business as Amerisourcebergen Drug Corp. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a delivery order with a firm fixed price of $1,672.16 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL to the Defense Logistics Agency (DLA). The $1,146.36 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 30, 2024, with a completion date of May 1, 2024. The contract is not designated with a set-aside requirement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of Lantus Solostar 100 Unit/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,501.75 firm fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This contract supports the DLA Troop Support Medical program, which provides medical commodities to military treatment facilities and veterans' healthcare programs. The contract has no set-aside designation,...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml medical products to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $1,259.40 and a completion date of February 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL syringes to the Defense Logistics Agency (DLA). The $1,398.28 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of August 8, 2023 and was awarded on August 7, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
- This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,837.04 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 29, 2024 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,022.80, is a delivery order for the provision of Lantus Solostar 100 Unit/ML 3ML medication. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRFN8Delivery Order
This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml prefilled syringes to the Defense Logistics Agency (DLA). The $1,689 firm-fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. Amerisourcebergen's parent company is Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 3/17/23 |